BURZYNSKI RESEARCH INSTITUTE INC (BZYR) is a Health Care company in the In Vitro & In Vivo Diagnostic Substances industry (SEC CIK 0000724445). Annual revenue was $0.00B in FY2025, compared to $0.00B in FY2021. Net income in FY2025 was $-0.00B (diluted EPS $-0.01).
| Metric | FY25Feb '25 | FY24Feb '24 | FY23Feb '23 | FY22Feb '22 | FY21Feb '21 |
|---|---|---|---|---|---|
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B |
| Net Income | $-0.00B | $-0.00B | $-0.00B | — | — |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Metric | FY25Feb '25 | FY24Feb '24 | FY23Feb '23 | FY22Feb '22 | FY21Feb '21 |
|---|---|---|---|---|---|
| Total Assets | $0.00B |
| Metric | FY25Feb '25 | FY24Feb '24 | FY23Feb '23 | FY22Feb '22 | FY21Feb '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.00B |
| Metric | FY25Feb '25 | FY24Feb '24 | FY23Feb '23 | FY22Feb '22 | FY21Feb '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001104659-26-059409 | May 7, 2026 | May 12, 2026 | May 12, 2026 20:15 UTC | EDGAR |
| 8-K | 0001104659-26-047711 | Apr 17, 2026 | Apr 23, 2026 | Apr 23, 2026 20:15 UTC | EDGAR |
| 10-Q | 0001104659-26-003337 | Nov 30, 2025 | Jan 13, 2026 | Jan 13, 2026 21:15 UTC | EDGAR |
| 10-Q | 0001104659-25-099284 | Aug 31, 2025 | Oct 14, 2025 | Oct 14, 2025 20:15 UTC | EDGAR |
| 8-K | 0001104659-25-070376 | Jul 21, 2025 | Jul 24, 2025 | Jul 24, 2025 20:15 UTC | EDGAR |
| 10-Q | 0001558370-25-009242 | May 31, 2025 | Jul 15, 2025 | Jul 15, 2025 20:15 UTC | EDGAR |
| 10-K | 0001558370-25-008021 | Feb 28, 2025 | May 20, 2025 | May 20, 2025 20:15 UTC | EDGAR |
| 10-Q | 0001558370-25-000165 | Nov 30, 2024 | Jan 13, 2025 | Jan 13, 2025 21:16 UTC | EDGAR |
Direct links to SEC EDGAR. BZYR has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $0.00B |
| $0.00B |
| $0.00B |
| $0.00B |
| Total Liabilities | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
|---|
| Stockholders' Equity | $-0.00B | $-0.00B | $-0.00B | $0.00B | $-0.00B |
|---|
| Cash & Equivalents | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
|---|
| Total Debt | — | — | — | — | — |
|---|
| $-0.00B |
| $-0.00B |
| $-0.00B |
| $-0.00B |
| Capital Expenditures | — | — | — | — | — |
|---|
| Free Cash Flow | — | — | — | — | — |
|---|
| — |
| — |
| — |
| Operating Margin | — | — | — | — | — |
|---|
| Net Margin | — | — | — | — | — |
|---|
| Return on Equity | 3329.3% | 5315.6% | 6675.1% | — | — |
|---|
| Return on Assets | -163660.8% | -57810.9% | -47378.1% | — | — |
|---|
| Debt / Equity | — | — | 2.86× | — | — |
|---|
